✦ LIBER ✦

Clinical phase I and pharmacokinetic study of S 16020, a new olivacine derivative: report on three infusion schedules

✍ Scribed by Awada, A.

Book ID: 126111430
Publisher: Oxford University Press
Year: 2002
Tongue: English
Weight: 151 KB
Volume: 13
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdf321

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial and pharmacokinetic (PK) s

Phase I trial and pharmacokinetic (PK) study of S16020 according to a weekly and every 2 week (W) schedule in cancer patients (PT)

✍ Brian, E.; Di Palma, M.; Etassami, A.; Quabdesselam, R.; Gérard, B.; Chouaki, N. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 269 KB

Pediatric Phase I Trial and Pharmacokine

Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium

✍ Aplenc, R.; Blaney, S. M.; Strauss, L. C.; Balis, F. M.; Shusterman, S.; Ingle, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 180 KB

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)

✍ C Terret; S Zanetta; H Roché; J.H.M Schellens; M.N Faber; J Wanders; M Ravic; J. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors

✍ Brigitte Tranchand; Gilles Catimel; Catherine Lucas; Marlis Sarkany; Gérard Bast 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 222 KB

570 A phase I study to determine the saf

570 A phase I study to determine the safety and pharmacokinetics of intravenous administration of SB715992 on a once weekly for three consecutive weeks schedule in patients with refractory solid tumors

✍ H. Burris III; P. LoRusso; S. Jones; J. McCormick; N. Willcutt; J. Hodge; P. Bus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 327 KB

99 Para-amino benzoic acid (PABA) modula

99 Para-amino benzoic acid (PABA) modulation of chemotherapy — evolution from preclinical work to a Phase I study. A report of early clinical activity including pharmacokinetic and pharmacodynamic studies

✍ A. Pavlick; L. Liebes; F. Muggia; K. Farrell; J. Goldberg; S. Mendoza; D. Fry; M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB